Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Hynes

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Journal of Mammary Gland Biology and Neoplasia|August 11, 2006
The mTOR pathway in breast cancerNancy E Hynes, Anne Boulay
Breast Cancer Research : BCR|October 24, 2009
Key signalling nodes in mammary gland development and cancer: MycNancy E Hynes, Tina Stoelzle
The Journal of Biological Chemistry|September 21, 2004
Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translationMagdalena Koziczak, Nancy E Hynes
Current Opinion in Cell Biology|February 12, 2009
ErbB receptors and signaling pathways in cancerNancy E Hynes, Gwen MacDonald
Cancer Discovery|May 16, 2012
The 14-3-3σ tumor suppressor has multiple functions in ErbB2-induced breast cancerNancy E Hynes, Tatiana Smirnova
Cancer Research|June 24, 2010
Potential for targeting the fibroblast growth factor receptors in breast cancerNancy E Hynes, Julien H Dey
Plos Biology|September 30, 2016
Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular OncologyBernd L Groner, Nancy E Hynes
Nature Reviews. Cancer|May 3, 2005
ERBB receptors and cancer: the complexity of targeted inhibitorsNancy E Hynes, Heidi A Lane
Cold Spring Harbor Perspectives in Biology|June 18, 2010
Mammary gland growth factors: roles in normal development and in cancerNancy E Hynes, Christine J Watson
Cancer Cell|May 5, 2009
PI3K inhibition overcomes trastuzumab resistance: blockade of ErbB2/ErbB3 is not always enoughNancy E Hynes, Julien H Dey
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Journal of Mammary Gland Biology and Neoplasia|August 11, 2006
The mTOR pathway in breast cancerNancy E Hynes, Anne Boulay
Breast Cancer Research : BCR|October 24, 2009
Key signalling nodes in mammary gland development and cancer: MycNancy E Hynes, Tina Stoelzle
The Journal of Biological Chemistry|September 21, 2004
Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translationMagdalena Koziczak, Nancy E Hynes
Current Opinion in Cell Biology|February 12, 2009
ErbB receptors and signaling pathways in cancerNancy E Hynes, Gwen MacDonald
Cancer Discovery|May 16, 2012
The 14-3-3σ tumor suppressor has multiple functions in ErbB2-induced breast cancerNancy E Hynes, Tatiana Smirnova
Cancer Research|June 24, 2010
Potential for targeting the fibroblast growth factor receptors in breast cancerNancy E Hynes, Julien H Dey
Plos Biology|September 30, 2016
Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular OncologyBernd L Groner, Nancy E Hynes
Nature Reviews. Cancer|May 3, 2005
ERBB receptors and cancer: the complexity of targeted inhibitorsNancy E Hynes, Heidi A Lane
Cold Spring Harbor Perspectives in Biology|June 18, 2010
Mammary gland growth factors: roles in normal development and in cancerNancy E Hynes, Christine J Watson
Cancer Cell|May 5, 2009
PI3K inhibition overcomes trastuzumab resistance: blockade of ErbB2/ErbB3 is not always enoughNancy E Hynes, Julien H Dey
Pageof 9